Switch to:
Teva Pharmaceutical Industries Ltd (NYSE:TEVA)
Cash Flow from Others
$2,978 Mil (TTM As of Dec. 2015)

Teva Pharmaceutical Industries Ltd's cash flow from others for the three months ended in Dec. 2015 was $853 Mil. Its cash flow from others for the trailing twelve months (TTM) ended in Dec. 2015 was $2,978 Mil.


Definition

Cash flow from others may include changes in working capital.

These are cash differences caused by the change of inventory, accounts payable, accounts receivable etc. For instance, if a company pays its suppliers slower, its cash position will build up faster. If a company receives payments from its customers slower, its account receivables will rise, and its cash position will grow more slowly (or even shrink).

Teva Pharmaceutical Industries Ltd Cash Flow from Others for the trailing twelve months (TTM) ended in Dec. 2015 was 353 (Mar. 2015 ) + 332 (Jun. 2015 ) + 1440 (Sep. 2015 ) + 853 (Dec. 2015 ) = $2,978 Mil.


Related Terms

Cash Flow from Operations


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Teva Pharmaceutical Industries Ltd Annual Data

Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13Dec14Dec15
Cash Flow from Others 1,388831,9311021441121,1486904181,316

Teva Pharmaceutical Industries Ltd Quarterly Data

Sep13Dec13Mar14Jun14Sep14Dec14Mar15Jun15Sep15Dec15
Cash Flow from Others 1323364063974415513533321,440853
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)

GuruFocus Premium Plus Membership

FEEDBACK